Please assess the completion status of the following clinical trial:

Trial Title: Increasing Patching for Amblyopia in Children 3 to < 8 Years Old

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Major Eligibility Criteria for Run-in Phase~* Age 3 to \< 8 years~* Amblyopia associated with strabismus, anisometropia, or both~* Visual acuity in the amblyopic eye between 20/50 and 20/400 inclusive~* Visual acuity in the sound eye 20/32 or better and inter-eye acuity difference \>3 logMAR lines~* Amblyopia treatment within the past 6 months subject to the following stipulations:~  * No more than 6 weeks of any amblyopia treatment other than spectacles (except for patients being treated with 2 hours of patching per day who are entering the study on treatment)~ * No simultaneous treatment with patching and atropine~ * No use of atropine in combination with the sound eye spectacle lens reduced by more than 1.50 D~ * Maximum level of treatment within the past 6 months:~    * Patching: up to 2 hours daily~   * Atropine: up to once daily~* Wearing spectacles with optimal correction (if applicable); if amblyopic eye acuity is 20/80 or better, then VA must be stable in glasses. If amblyopic eye acuity is 20/100 or worse, then spectacles and patching can be initiated simultaneously.~Eligibility Criteria for Randomization:~* Amblyopic eye acuity of 20/40 to 20/160 with an inter-ocular difference of \>2 lines, or amblyopic eye acuity of 20/32 with 3 lines of IOD.~* Reasonable compliance with prescribed treatment, defined as wearing the patch at least 10 hours per week.~Exclusion Criteria:~* Currently using vision therapy or orthoptics~* Ocular cause for reduced visual acuity (nystagmus per se does not exclude the patient if the above visual acuity criteria are met)~* Prior intraocular or refractive surgery~* Known skin reaction to patch or bandage adhesives

- Gender: ALL
- Minimum Age: 3 Years
- Maximum Age: 7 Years
- Healthy Volunteers: f

Study Arms:
- Control (Type: ACTIVE_COMPARATOR): 2 hours daily patching
- Intensified treatment (Type: ACTIVE_COMPARATOR): 42 hours per week of patching (averaging 6 hours daily)

Based on this trial design, predict the completion outcome and termination type (if applicable).